Clinical Ink is the leading provider of eSource solutions for the global clinical trials market. Founded in 2007, Clinical Ink is dedicated to transforming clinical development – from Start to Submit™ – by creating a completely paperless clinical trial platform for sites, sponsors, CROs and patients. Clinical Ink’s SureSource platform is purpose-built to capture eSource data ad documents electronically at the site, while the CentrosHealth patient engagement platform provides patients with a variety of configurable apps to keep them informed, involved and compliant throughout the duration of a clinical trial. Clinical Ink maintains offices in Winston-Salem, NC, Philadelphia, PA and Cambridge, MA. Additional information is available online at or toll-free 1-800-301-5033. Our customer base includes pharmaceutical and medical device companies, academic institutions, and CROs. SureSource has been successfully used in a wide range of therapeutic areas including CNS, infectious diseases, dermatology, gastroenterology, and virology.
Winston-Salem, US
Size (employees)
88 (est)+2%
Clinical Ink was founded in 2007 and is headquartered in Winston-Salem, US
Report incorrect company information

Key People/Management at Clinical Ink

Edward S. Seguine

Edward S. Seguine

Doug Pierce

Doug Pierce


Clinical Ink Office Locations

Clinical Ink has an office in Winston-Salem, Cary, Horsham and Cambridge
Winston-Salem, US (HQ)
130 525 Vine St
Cambridge, US
10 Canal Park
Cary, US
200 1000 Centregreen Way
Horsham, US
150 110 Gibraltar Rd
Show all (4)
Report incorrect company information

Clinical Ink Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$24.3 m

Latest funding size

$24.30 m

Time since last funding

2 years ago
Clinical Ink's latest funding round in February 2016 was reported to be $24.3 m. In total, Clinical Ink has raised $24.3 m
Report incorrect company information